Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,740 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of in vivo eccentricity and symmetry indices between metallic stents and bioresorbable vascular scaffolds: insights from the ABSORB and SPIRIT trials.
Brugaletta S, Gomez-Lara J, Diletti R, Farooq V, van Geuns RJ, de Bruyne B, Dudek D, Garcia-Garcia HM, Ormiston JA, Serruys PW. Brugaletta S, et al. Among authors: serruys pw. Catheter Cardiovasc Interv. 2012 Feb 1;79(2):219-28. doi: 10.1002/ccd.22996. Epub 2011 May 11. Catheter Cardiovasc Interv. 2012. PMID: 21563288 Clinical Trial.
Angiographic and clinical one-year follow-up of the Cordis tantalum coil stent in a multicenter international study demonstrating improved restenosis rates when compared to pooled PTCA and BENESTENT-I data: the European Antiplatelet Stent Investigation (EASI).
Rothman M, Serruys P, Grollier G, Hoorntje J, van Den Bos A, Wijns W, Gershlick A, Van Es G, Melkert R, Eijgelshoven M, Lenderink T, Richardson G, Dille-Amo C; European Antiplatelet Stent Investigation. Rothman M, et al. Catheter Cardiovasc Interv. 2001 Feb;52(2):249-59. doi: 10.1002/1522-726x(200102)52:2<249::aid-ccd1060>3.0.co;2-t. Catheter Cardiovasc Interv. 2001. PMID: 11170341
A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study.
Serruys PW, Foley DP, Suttorp MJ, Rensing BJ, Suryapranata H, Materne P, van den Bos A, Benit E, Anzuini A, Rutsch W, Legrand V, Dawkins K, Cobaugh M, Bressers M, Backx B, Wijns W, Colombo A. Serruys PW, et al. J Am Coll Cardiol. 2002 Feb 6;39(3):393-9. doi: 10.1016/s0735-1097(01)01760-0. J Am Coll Cardiol. 2002. PMID: 11823075 Free article. Clinical Trial.
A new intracoronary measurement catheter, MetriCath, compared to intravascular ultrasound and quantitative coronary angiography in a stented porcine coronary model.
van der Giessen WJ, Carlier SG, Regar E, van Beusekom HM, Foley DP, de Feyter PJ, Verdouw PD, Boersma E, Wolthuis R, Serruys PW. van der Giessen WJ, et al. Among authors: serruys pw. Catheter Cardiovasc Interv. 2002 Sep;57(1):2-9; discussion 10-1. doi: 10.1002/ccd.10242. Catheter Cardiovasc Interv. 2002. PMID: 12203919
Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up.
Degertekin M, Serruys PW, Foley DP, Tanabe K, Regar E, Vos J, Smits PC, van der Giessen WJ, van den Brand M, de Feyter P, Popma JJ. Degertekin M, et al. Among authors: serruys pw. Circulation. 2002 Sep 24;106(13):1610-3. doi: 10.1161/01.cir.0000034447.02535.d5. Circulation. 2002. PMID: 12270850 Clinical Trial.
TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation.
Tanabe K, Serruys PW, Grube E, Smits PC, Selbach G, van der Giessen WJ, Staberock M, de Feyter P, Müller R, Regar E, Degertekin M, Ligthart JM, Disco C, Backx B, Russell ME. Tanabe K, et al. Among authors: serruys pw. Circulation. 2003 Feb 4;107(4):559-64. doi: 10.1161/01.cir.0000048184.96491.8a. Circulation. 2003. PMID: 12566366 Clinical Trial.
Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases.
Lemos PA, Saia F, Ligthart JM, Arampatzis CA, Sianos G, Tanabe K, Hoye A, Degertekin M, Daemen J, McFadden E, Hofma S, Smits PC, de Feyter P, van der Giessen WJ, van Domburg RT, Serruys PW. Lemos PA, et al. Among authors: serruys pw. Circulation. 2003 Jul 22;108(3):257-60. doi: 10.1161/01.CIR.0000083366.33686.11. Epub 2003 Jul 14. Circulation. 2003. PMID: 12860901 Clinical Trial.
Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery disease.
Arampatzis CA, Lemos PA, Tanabe K, Hoye A, Degertekin M, Saia F, Lee CH, Ruiter A, McFadden E, Sianos G, Smits PC, van der Giessen WJ, de Feijter P, van Domburg R, Serruys PW. Arampatzis CA, et al. Among authors: serruys pw. Am J Cardiol. 2003 Aug 1;92(3):327-9. doi: 10.1016/s0002-9149(03)00640-4. Am J Cardiol. 2003. PMID: 12888147 Clinical Trial.
2,740 results